Degradable metallic biomaterials: The concept, current developments and future directions

Minerva Biotecnologica

Volumn 21, Issue 4, 2009, Pages 207-216

  Hermawan, H ^a   Mantovani, D ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Absorbable implants; Biocompatible materials; Surgical procedures, operative

Indexed keywords

ALLOY; BIOMATERIAL; CALCIUM; CHROMIUM; GADOLINIUM; IRON; LITHIUM; MAGNESIUM; MANGANESE; PALLADIUM; YTTRIUM; ZINC;

ARTERY OCCLUSION; BIODEGRADABLE IMPLANT; CONGENITAL HEART MALFORMATION; CORONARY STENT; CYTOTOXICITY; FRACTURE; FRACTURE FIXATION; HEALING; HUMAN; METAL IMPLANTATION; NONHUMAN; REVIEW;

ANIMALIA;

EID: 77951915002     PISSN: 11204826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. US National Library of Medicine and the National Institutes of Health. [Accessed 2009 October 30; cited 2009 December 1]. Available at: http://www.ncbi.nlm.nih.gov/pubmed.
2. United States Patent and Trademark Office. [Accessed 2009 October 30; cited 2009 December 1]. Available at: http://www.uspto.gov.
3. First Symposium on Degradable Metals for Biomedical Applications. International Conference on Processing and Manufacturing of Advanced Materials (THERMEC'2009). Berlin, Germany; 2009 August 25-29.
4. Stack RS, Califf RM, Phillips HR, Pryor DB, Quigley PJ, Bauman RP et al. Interventional cardiac catheterization at Duke Medical Center. Am J Cardiol 1988;62:3F-24F.
5. Tamai H, Igaki K, Kyo E, Kosuga K, Kawashima A, Matsui S et al. Initial and 6-month results of biodegradable poly-1-lactic acid coronary stents in humans. Circulation 2000;102:399-404.
6. van der Giessen WJ, Lincoff AM, Schwartz RS, van Beusekom HM, Serruys PW, Holmes DR Jr et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996;94:1690-1697
7. Heublein B, Rohde R, Kaese V, Niemeyer M, Hartung W, Haverich A. Biocorrosion of magnesium alloys: A new principle in cardiovascular implant technology? Heart 2003;89:651-656
8. Levesque J, Dube D, Fiset M, Mantovani D. Investigation of corrosion behaviour of magnesium alloy AM60B-F under pseudo-physiological conditions. Mater Sci Forum 2003;426-432:521-526
9. Witte F, Kaese V, Haferkamp H, Switzer E, Linderberg AM, Wirth CJ et al. In vivo corrosion of four magnesium alloys and the associated bone response. Biomaterials 2005;26:3557-3563
10. Xin Y, Liu C, Zhang X, Tang G, Tian X, Chu PK. Corrosion behavior of biomedical AZ91 magnesium alloy in simulated body fluids. J Mater Res 2007;22:2004-2011
11. Di Mario C, Griffiths H, Goktekin O, Peeters N, Verbist J, Bosiers M et al. Drug-eluting bioabsorbable magnesium stent. J Interv Cardiol 2004;17:391-395
12. Peeters P, Bosiers M, Verbist J, Deloose K, Heublein B. Preliminary results after application of absorbable metal stents in patients with critical limb ischemia. J Endovasc Ther 2005;12:1-5.
13. Waksman R, Pakala R, Kuchulakanti PK, Baffour R, Hellinga D, Seabron R et al. Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries. Catheter Cardiovasc Interv 2006;68:606-617
14. Hänzi AC, Sologubenko AS, Uggowitzer PJ. Design strategy for microalloyed ultra-ductile magnesium alloys for medical applications. Mater Sci Forum 2009;618-619:75-82.
15. Zhang E, Yang L. Microstructure, mechanical properties and biocorrosion properties of Mg-Zn-Mn-Ca alloy for biomedical application. Mater Sci Eng A 2008;497:111-118
16. Li Z, Gu X, Lou S, Zheng Y. The development of binary Mg-Ca alloys for use as biodegradable materials within bones. Biomaterials 2008;29:1329-1344
17. Peuster M, Wohlsein P, Brugmann M, Ehlerding M, Seidler K, Fink C, Brauer H, Fischer A, Hausdorf G. A novel approach to temporary stenting: Degradable cardiovascular stents produced from corrodible metal-results 6-18 months after implantation into New Zealand white rabbits. Heart 2001;86:563-569
18. Peuster M, Hesse C, Schloo T, Fink C, Beerbaum P, von Schnakenburg C. Long-term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta. Biomaterials 2006;27:4955-4962
19. Hermawan H, Alamdari H, Mantovani D, Dubé D. Iron-manganese: New class of degradable metallic biomaterials prepared by powder metallurgy. Powder Metall 2008;51:38-45.
20. Schinhammer M, Hänzi AC, Löffler JF, Uggowitzer PJ. Design strategy for biodegradable Fe-based alloys for medical applications. Acta Biomater 2009:doi:10.10l6/j.actbio.2009.1007.1039.
21. Hermawan H, Dube D, Mantovani D. Developments in metallic biodegradable stents. Acta Biomater 2009:doi:10.10l6/j.actbio.20091010.1006.
22. El-Omar MM, Dangas G, Iakovou I, Mehran R. Update on in-stent restenosis. Curr Interv Cardiol Rep 2001;3:296-305.
23. Schomig A, Kastrati A, Mudra H, Blasini R, Schuhlen H, Klauss V et al. Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure. Circulation 1994;90:2716-2724
24. Serruys PW, Kutryk MJ, Ong AT. Coronary-artery stents. N Engl J Med 2006;354:483-495
25. ASTM F138: Standard specification for wrought 18chromium-1l4nickel-2. 5molybdenum stainless steel bar and wire for surgical implants (UNS S31673). West Conshohocken: ASTM International; 2003
26. Goodfellow Corporation. Iron (Fe) - material information. [Accessed 2009 May 05; cited 2009 December 1). Available at: http://www.goodfellow.com/csp/ active/STATIC/A/Iron.HTML.
27. ASM Handbook volume 2: Properties and selection: nonferrous alloys and special purpose materials. Materials Park: ASM International; 2005
28. ASTM B80: Standard specification for magnesium-alloy sand castings. West Conshohocken: ASTM International; 2001.
29. Kannan MB, Raman RKS. In vitro degradation and mechanical integrity of calcium-containing magnesium alloys in modified-simulated body fluid. Biomaterials 2008;29:2306-2314
30. Yuen CK, Ip WY. Theoretical risk assessment of magnesium alloys as degradable biomedical implants. Acta Biomater 2009 [In press].
31. Li L, Gao J, Wang Y. Evaluation of cyto-toxicity and corrosion behavior of alkali-heat-treated magnesium in simulated body fluid. Surf Coat Technol 2004;185:92-98
32. The ISO 10993-10995: Biological evaluation of medical devices-Part 5: Tests for in vitro cytotoxicity. Arlington, VA: ANSI/AAMI; 1999.
33. Pietak A, Mahoney P, Dias GJ, Staiger MP. Bone-like matrix formation on magnesium and magnesium alloys. J Mater Sci Mater Med 2008;19:407-415
34. Witte F, Feyerabend F, Maier P, Fischer J, Störmer M, Blawert C et al. Biodegradable magnesium-hydroxyapatite metal matrix composites. Biomaterials 2007;28:2163-2174
35. Zhu S, Huang N, Xu L, Zhang Y, Liu H, Sun H et al. Biocompatibility of pure iron: In vitro assessment of degradation kinetics and cytotoxicity on endothelial cells. Mater Sci Eng C 2009;29:1589-1592
36. Hermawan H, Purnama A, Dube D, Couet J, Mantovani D. Fe-Mn alloys for metallic biodegradable stents: Degradation and cell viability studies. Acta Biomater 2009 [In press].
37. Gu X, Zheng Y, Cheng Y, Zhong S, Xi T. In vitro corrosion and biocompatibility of binary magnesium alloys. Biomaterials 2009;30:484-98.
38. Feyerabend F, Fischer J, Holtz J, Witte F, Willumeit R, Drücker H et al. Evaluation of short-term effects of rare earth and other elements used in magnesium alloys on primary cells and cell lines. Acta Biomater 2009: doi:10.10l6/j.actbio.2009.09.024.
39. Drynda A, Deinet N, Braun N, Peuster M. Rare earth metals used in biodegradable magnesium-based stents do not interfere with proliferation of smooth muscle cells but do induce the upregulation of inflammatory genes. J Biomed Mater Res A 2009;91:360-369
40. Waksman R, Pakala R, Baffour R, Seabron R, Hellinga D, Tio FO. Short-term effects of biocorrodible iron stents in porcine coronary arteries. J Interv Cardiol 2008;21:15-20.
41. Waksman R, Pakala R, Okabe T, Hellinga D, Chan R, Tio MO etal. Efficacy and safety of absorbable metallic stents with adjunct intracoronary beta radiation in porcine coronary arteries. J Interv Cardiol 2007;20:367-372
42. Zhang E, Xu L, Yu G, Pan F, Yang K. In vivo evaluation of biodegradable magnesium alloy bone implant in the first 6 months implantation. J Biomed Mater Res A 2009;90:882-893
43. Schranz D, Zartner P, Michel-Behnke I, Akinturk H. Bioabsorbable metal stents for percutaneous treatment of critical recoarctation of the aorta in a newborn. Catheter Cardiovasc Interv 2006;67:671-673
44. Zartner P, Cesnjevar R, Singer H, Weyand M. First successful implantation of a biodegradable metal stent into the left pulmonary artery of a preterm baby. Catheter Cardiovasc Interv 2005;66:590-594
45. Zartner P, Buettner M, Singer H, Sigler M. First biodegradable metal stent in a child with congenital heart disease: Evaluation of macro and histopathology. Catheter Cardiovasc Interv 2007;69:443-6.
46. McMahon CJ, Oslizlok P, Walsh KP. Early restenosis following biodegradable stent implantation in an aortopulmonary collateral of a patient with pulmonary atresia and hypoplastic pulmonary arteries. Catheter Cardiovasc Interv 2007;69:735-738
47. Erbel R, Di Mario C, Bartunek J, Bonnier J, de Bruyne B, Eberli FR et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: A prospective, non-randomised multicentre trial. Lancet 2007;369:1869-1875
48. Bosiers M, Peeters P, D'Archambeau O, Hendriks J, Pilger E, Duber C et al. AMS INSIGHT - Absorbable Metal Stent Implantation for Treatment of Below-the-Knee Critical Limb Ischemia: 6-Month Analysis. Cardiovasc Intervent Radiol 2009:doi:10.1007/s00270-00008-09472-00278.
49. Yun Y, Dong Z, Lee N, Liu Y, Xue D, Guo X et al. Revolutionizing biodegradable metals. Materials Today 2009;12:22-32.
50. Witte F, Fischer J, Nellesen J, Vogt C, Vogt J, Donath T et al. In vivo corrosion and corrosion protection of magnesium alloy LAE442. Acta Biomater 2009:doi:10.10l6/j.actbio.2009.1010.1012.
51. Purnama A, Hermawan H, Couet J, Mantovani D. Assessing the biocompatibility of degradable metallic materials: State of the art and focus on the genetic regulation potential. Acta Biomater 2009 [In press].